Ntawm 2021-12-06, peb lub sijhawm, tsev kawm ntawv cov tshuaj (NASDAQ: Kawm kom paub cov ntsiab lus ntawm nws cov tshuaj uas muaj kev sib tw. Theem III mus sib hais, yog siv los ntsuas lavender, yog tsuas yog siv los ntsuas qhov kev nyab xeeb thiab ua tau zoo ntawm kev kho mob ntawm kev rov sensdrome (Rs). Tag nrho ntawm 189 tus kawm tau cuv npe, txhua tus poj niam hnub nyoog 5-20 xyoo nrog Rs.
Lavender yog ob-qhov muag tsis pom kev, randomized, remined Prospatchnoint (Rsbq Tus yuam sij theem nrab yog cov kev sib txuas lus thiab cov cim qhia txog kev ua haujlwm ntawm cov menyuam mos thiab cov menyuam yaus (CSBS)
Cov txiaj ntsig tau pom tias Trofinnide muaj qhov tseem ceeb txhim kho hauv ob qho kev txiav txim siab thawj zaug piv rau cov ntsiab lus. Kev hloov pauv ntawm cov hauv paus hauv RSBQ rau placebo thiab trofinnide thaum lub lim tiam 12 yog -1.7 vs -5.1 (p = 0.0175); CGI-I tau qhab nias tau 3.8 vs 3.5 (p = 0.0030). Lub caij no, kev hloov pauv ntawm Baseline hauv CSBS-DP-nws-kev sib raug zoo yog -1.1 thiab -0.1 rau plofinbo thiab trofinning, ntsig txog.
Ob qho tib si thawj tus thawj thiab theem theem theem theem ob pom tau tias muaj peev xwm tshawb fawb txog kev kawm tsis meej txog kev ua kom pom kev zoo rau kev ua kom pom kev zoo rau cov kev tshawb fawb, ob yog 2.1%, feem. Ntawm lawv, feem ntau cov xwm txheej tshwj xeeb tshaj yog:
① Zawv plab - Trofinnide yog 80.6% (9.6% ntawm uas yog qhov me me rau cua) thiab placebo yog 19.1%;
② Ntuav - Trofinnide yog 26.9% (96% ntawm uas yog me me rau cua) thiab placebo yog 9.6%;
③ cov xwm txheej tsis zoo tshwm sim hauv 3.2% ntawm cov kev kawm hauv ob pab pawg.
Cov kawm nyob rau hauv cov pajtsender yuav tau txais kev tshawb fawb ntxiv tom qab kev kawm txog lilac, thiab cov kev tshawb pom kev nthuav dav rau qhov kev sib tham kho mob tom ntej.
Lub Sijhawm Post: Feb-17-2022